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Abstract
Background: MicroRNAs (miRNAs) are a large class of tiny non-coding RNAs (~22-24 nt) that regulate diverse 
biological processes at the posttranscriptional level by controlling mRNA stability or translation. As a molecular switch, 
the canonical Wnt/β-catenin signaling pathway should be suppressed during the adipogenesis; However, activation of 
this pathway leads to the inhibition of lipid depots formation. The aim of our studies was to identify miRNAs that might 
be involved in adipogenesis by modulating WNT signaling pathway. Here we established two types of cell model, 
activation and repression of WNT signaling, and investigated the expression profile of microRNAs using microarray 
assay.
Results: The high throughput microarray data revealed 18 miRNAs that might promote adipogenesis by repressing 
WNT signaling: miR-210, miR-148a, miR-194, miR-322 etc. Meanwhile, we also identified 29 miRNAs that might have 
negative effect on adipogenesis by activating WNT signaling: miR-344, miR-27 and miR-181 etc. The targets of these 
miRNAs were also analysed by bioinformatics. To validate the predicted targets and the potential functions of these 
identified miRNAs, the mimics of miR-210 were transfected into 3T3-L1 cells and enlarged cells with distinct lipid 
droplets were observed; Meanwhile, transfection with the inhibitor of miR-210 could markedly decrease 
differentiation-specific factors at the transcription level, which suggested the specific role of miR-210 in promoting 
adipogenesis. Tcf7l2, the predicted target of miR-210, is a transcription factor triggering the downstream responsive 
genes of WNT signaling, was blocked at transcription level. Furthermore, the activity of luciferase reporter bearing 
Tcf7l2 mRNA 3' UTR was decreased after co-transfection with miR-210 in HEK-293FT cells. Last but not least, the protein 
expression level of β-catenin was increased in the lithium (LiCl) treated 3T3-L1 cells after transfection with miR-210. 
These findings suggested that miR-210 could promote adipogenesis by repressing WNT signaling through targeting 
Tcf7l2.
Conclusions: The results suggest the presence of miRNAs in two cell models, providing insights into WNT pathway-
specific miRNAs that can be further characterized for their potential roles in adipogenesis. To our knowledge, present 
study represents the first attempt to unveil the profile of miRNAs involed in adipogenesis by modulating WNT signaling 
pathway, which contributed to deeper investigation of the mechanism of adipogenesis.
Background
Adipogenesis is the development of fat cells from preadi-
pocytes to mature adipocytes, and has been one of the
most intense studied models of cellular differentiation
[1], which implicated in insulin resistance, type 2 diabe-
tes, hypertension and atherosclerosis, collectively called
the metabolic syndrome (MS)[2]. Wingless-type MMTV
integration site family (WNTs) is indispensable for the
regulation of adipogenesis [3-5], which is a family of
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secreted glycoproteins with autocrine and paracrine
effects on the regulation of cell proliferation, survival, fate
and behavior [6,7]. In canonical WNT signaling, WNT
members bind to frizzled (FZD) receptors and low-den-
sity lipoprotein receptor-related protein-5 or -6 (LRP5/6)
co-receptors, leading to inactivation of the degradation
complex that includes glycogen synthase kinase (GSK)-
3β, axin and adenomatous polyposis coli (APC), in turn
blocking β-catenin phosphorylation by GSK-3β. Hypo-
phosphorylation of β-catenin and translocation into the
nucleus leads to binding with members of the lymphoid-
enhancer-binding factor/T-cell-specific transcription fac-
tor (LEF/TCF) family and activation of WNT target
genes [8,9]. As a member of LEF/TCF family, transcrip-
tion factor 7 like 2 (Tcf7l2, formerly called Tcf4) is an
important transcription factor triggering the downstream
responsive genes of WNT signaling [10]. Previous
research has shown that WNT signaling represses adipo-
cyte differentiation by blocking the expression of Pparg
and Cebpa, two transcription factors indispensable for
adipogenesis [5]. Wnt10b was first identified as an inhibi-
tor of adipogenesis, which must be suppressed for pre-
adipocytes to differentiate in vitro [5]. In vivo experi-
ments also demonstrated that Wnt-10b transgenic mice
showed a similar decline in total body fat as well as peri-
renal depots [11]. Ectopic expression of Wnt-1 in 3T3-L1
pre-adipocytes blocked adipogenesis [12]. Together, these
results indicated that the Wnt/β-catenin signaling path-
way suppresses adipocyte differentiation and is therefore
a molecular switch of adipogenesis; once it is activated,
pre-adipocytes are maintained in an undifferentiated
state [8].
Recently, it has been found that RNAs of a new class of
noncoding RNAs, microRNAs (miRNAs), regulate gene
expression in metazoans from C. elegans to humans
[13,14]. miRNAs are endogenous non-coding RNAs, 22-
24 nucleotides in length, which are demonstrated to
modulate diverse biological processes through negatively
regulating gene expressions posttranscriptionally by con-
trolling mRNA stability or translation[15]. Many studies
have shown that miRNAs participate in multiple meta-
bolic processes including energy homeostasis, sugar/lipid
metabolism and cell differentiation. In the development
of lipogenesis, miR-143 was first reported to be up-regu-
lated in human pre-adipocytes [16,17] and in adult mice
in vivo [18], suggesting that it was involved in adipocyte
differentiation; miR-375 has also been reported to pro-
mote 3T3-L1 preadipocytes differentiation [19]. To sum
up, these findings indicated that WNT signaling and
miRNAs have regulatory roles in adipogenesis.
To investigate which miRNAs might modulate WNT
signaling during adipogenesis, we screened out the pupa-
tive miRNAs using microarray assay. Here we used 3T3-
L1 cells to establish two models by different treatments.
One treatment was to induce differentiation with an MDI
cocktail (methylxanthine, dexamethasone and insulin),
suppressing WNT signaling. The other was to treat the
cells with lithium (LiCl), which is an inhibitor of GSK-3β
that further blocks the phosphorylation of β-catenin,
resulting in activation of WNT signaling [5]. The differ-
ent miRNA expression patterns of the two models were
investigated by a mouse miRNA microarray, enabling us
to screen out a number of miRNAs that might regulate
adipogenesis by activating or repressing the WNT signal-
ing pathway.
Results
Cell models construction
In model 1, pre-adipocytes (Figure 1, A, G) were induced
to differentiate into mature adipocytes by MDI induction
assay; enlarged cells with distinct lipid droplets were
observed under the light microscope (Figure 1, B, C, G).
In model 2, the pre-adipocytes treating with lithium
before MDI induction (Figure 1, D, G) failed to differenti-
ate into mature adipocytes (Figure 1, E, G), as confirmed
by oil red O staining (Figure 1, F, G). As a control, NaCl
was used in place of LiCl before MDI induction, the pre-
a d i p o c y t e s  d i f f e r e n t i a t e d  n o r m a l l y  i n t o  m a t u r e  a d i p o -
cytes (Additional file 1). The following molecular data
Figure 1 Construction of two cell models. (A) Pre-adipocytes; (B) 
Mature adipocytes differentiated for 7 days; (C) Oil red O staining of 
mature adipocytes; (D) Pre-adipocytes treated with lithium; (E) Induc-
tion of lithium-treated preadipocytes (Li+MDI) for 7 days; (F) Oil red 
staining of Li+MDI cells. (G) Low amplification of the two cell models. 
(H) Lithium activated the expression of Cyclin D1 and c-Myc at tran-
scription level in 3T3-L1 cells.Qin et al. BMC Genomics 2010, 11:320
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were fully consistent with these morphological findings.
Target genes of the WNT signaling pathway such as
Cyclin D1 and  c-Myc  were markedly more highly
expressed in model 2 than model 1 cells (Figure 1, H). In
time course experiments with model 1, several transcrip-
tion factors such as Pparg, Cebpa and Add1 and differen-
tiation-specific genes such as aP2 and adiponectin [20,21]
increased significantly during adipogenesis. Interestingly,
these genes were blocked completely in model 2 (Figure
2; Additional file 2). Both the morphological and molecu-
lar data showed that WNT signaling was dramatically
suppressed and adipogenesis promoted in model 1, while
in model 2, WNT signaling was activated and adipogene-
sis totally repressed. This suggested that the cell models
had been constructed successfully.
miRNA expression profile revealed by microarray data
(1) Expression profile of differentiation-specific miRNAs
To identify the miRNA related to adipocyte differentia-
tion, miRNA expression in pre-adipocytes and adipo-
cytes was analyzed by microarray. The results showed
that 26 miRNAs underwent at least twofold changes, sig-
nificant at P < 0.05 (Table 1, Additional file 3). Compari-
son between the two sets screened out most miRNAs;
Nine were down-regulated and 17 up-regulated in the
pre-adipocytes. Remarkably, miR-582-5p and miR-99a
were up-regulated 6-fold and 5.24-fold respectively in
mature adipocytes. Conversely, miR-196a and miR-130b
were down-regulated 7- and 2.85-fold respectively in
mature adipocytes. These were all significant differences
(P < 0.01).
Figure 2 The molecular evidence of cell models construction. (A) 
Expression of Pparg, Cebpa, and Add1; (B) Adiponectin and (C) aP2 
during induction in the two cell models. X-axis indicated the time 
course of differentiation. d0, d1, d3, d5, d7 mean the days of MDI in-
duced differentiation; Lid0, Lid1, Lid3, Lid5, Lid7 mean the days of MDI 
induced differentiation of cells treated with Lithium. Y-axis indicates 
the expression of the detected genes relative to the internal reference 
gene Gapdh.
Table 1: Different expression of miRNAs between pre-
adipocytes and mature adipocytes.
miRNA P-value Fold change Regulation
mmu-miR-30e 0.00 2.30 up
mmu-miR-107 0.04 2.68 up
mmu-miR-468 0.05 3.03 up
mmu-miR-542-5p 0.02 4.38 up
mmu-let-7c 0.00 3.20 up
mmu-miR-582-5p 0.01 6.25 up
mmu-miR-335-5p 0.03 3.16 up
mmu-miR-10b 0.01 2.47 up
mmu-miR-101a 0.05 2.43 up
mmu-miR-99a 0.01 5.24 up
mmu-miR-101b 0.00 2.93 up
mmu-miR-146b 0.00 4.70 up
mmu-miR-210 0.03 2.41 up
mmu-miR-148a 0.00 2.99 up
mmu-miR-194 0.01 5.29 up
mmu-miR-103 0.02 3.70 up
mmu-miR-192 0.01 2.10 up
mmu-miR-29b 0.01 2.06 down
mmu-let-7e 0.03 2.16 down
mmu-miR-344 0.03 2.87 down
mmu-miR-196a 0.01 7.37 down
mmu-miR-140 0.00 2.03 down
mmu-miR-872 0.01 2.13 down
mmu-miR-130b 0.01 2.85 down
mmu-miR-140* 0.00 2.12 down
mmu-miR-34b-3p 0.01 2.00 down
Up-regulation means the expression of the miRNAs are higher in 
mature adipocytes than pre-adipocytes; Down-regulation is the 
reverse.Qin et al. BMC Genomics 2010, 11:320
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(2) Expression profile of WNT pathway-specific miRNAs
To investigate miRNA profiles associated with the WNT
signaling activation, miRNA expression between the
preadipocytes treating with or without lithium was ana-
lyzed by microarray. The results showed 15 miRNAs dif-
fer-expression for twofold, significant at P < 0.05 (Table 2,
Additional file 4). Seven of these were up-regulated and
eight down-regulated in lithium-treated pre-adipocytes.
miR-322* was down-regulated 3.72-fold and miR-183*
was up-regulated significantly (P < 0.01) changing 4-fold,
in lithium-treated pre-adipocytes. Notably, miR-503 was
down-regulated dramatically, nearly 8-fold (P < 0.05), in
these cells.
(3) Expression profile of WNT pathway-specific miRNAs by 
further induction in lithium-treated cells
To clarify further the pattern of miRNAs specific to
WNT signaling, we reinvestigated the miRNAs that were
differentially expressed between the MDI (Figure 1, B)
and Li+MDI (Figure 1, E) groups. As observed by light
microscopy, Li+MDI-treated cells did not differentiate
into mature adipocytes (Figure 1, E, F), while the cells of
the MDI group differentiated fully (Figure 1, B, C).
Microarray analysis showed that 23 miRNAs differed at
least two-fold between these treatments (Table 3, Addi-
tional file 5): Ten were down-regulated and 13 up-regu-
lated in the Li+MDI group. In Li+MDI-treated cells, miR-
24-1* and miR-301a were up-regulated 4.31- and 3.72-
fold respectively, whereas miR-468 was down-regulated
3.42-fold; all those differences were significant (P < 0.01).
Remarkably, miR-344 was up-regulated about 10-fold and
miR-322 down-regulated about 6-fold in Li+MDI-treated
cells.
Validation of microarray by real time qRT-PCR
To confirm the accuracy of the miRNA microarray, stem-
loop polymerase chain reaction (qRT-PCR) assay was
performed on several miRNAs chosen at random [22,23].
To determine whether there was a similar trend between
the microarray and real time qPCR results, the latter were
normalized by fold amplification. As shown in Figure 3,
t h e  q R T - P C R  d a t a  ( A d d i t i o n a l  f i l e  2 )  m a p p e d  t h e
microarray results closely. For example, the microarray
data showed that miR-186 expression was higher in lith-
ium-treated preadipocytes than in untreated preadipo-
cytes, and the same trend was also observed in the qRT-
Table 2: Different expression of miRNAs between pre-
adipocytes and lithium-treated pre-adipocytes.
miRNA P-value Fold change Regulation
mmu-miR-183* 0.00 4.16 up
mmu-miR-186 0.01 2.08 up
mmu-miR-582-5p 0.03 3.17 up
mmu-miR-344 0.01 2.47 up
mmu-miR-24-1* 0.04 2.69 up
mmu-miR-18a* 0.01 2.40 up
mmu-miR-7a* 0.04 3.58 up
mmu-miR-322 0.01 2.91 down
mmu-miR-542-5p 0.03 3.58 down
mmu-miR-351 0.03 2.32 down
mmu-miR-322* 0.04 3.72 down
mmu-miR-214 0.02 2.19 down
mmu-miR-196a 0.03 3.06 down
mmu-miR-146b 0.02 2.85 down
mmu-miR-503 0.02 7.96 down
Up-regulation means the expression of the miRNAs are higher in 
lithium-treated pre-adipocytes than pre-adipocytes; Down-
regulation means the expression of the miRNAs are lower in lithium-
treated pre-adipocytes than pre-adipocytes.
Table 3: Different expression of miRNAs between MDI and 
Li+MDI cells.
miRNA P-value Fold change Regulation
mmu-miR-27b 0.00 2.80 up
mmu-let-7e 0.04 2.22 up
mmu-miR-301a 0.00 3.73 up
mmu-miR-23b 0.01 3.29 up
mmu-miR-344 0.00 9.84 up
mmu-miR-320 0.04 2.05 up
mmu-miR-222 0.01 2.17 up
mmu-miR-24-1* 0.01 4.31 up
mmu-miR-181b 0.04 2.12 up
mmu-miR-181a-1* 0.02 2.47 up
mmu-miR-7a* 0.01 2.59 up
mmu-miR-714 0.02 2.55 up
mmu-miR-181d 0.04 4.25 up
mmu-miR-322 0.01 5.55 down
mmu-miR-450a-5p 0.04 2.65 down
mmu-miR-468 0.01 3.42 down
mmu-miR-542-5p 0.02 2.32 down
mmu-let-7c 0.01 2.31 down
mmu-miR-335-5p 0.03 3.07 down
mmu-let-7c-1* 0.05 2.26 down
mmu-miR-30a 0.01 2.36 down
mmu-miR-148a 0.01 2.04 down
mmu-miR-194 0.02 2.24 down
Up-regulation means the expression of the miRNAs are higher in 
Li+MDI cells than MDI cells; Down-regulation means the expression 
of the miRNAs are lower in Li+MDI cells than MDI cells.Qin et al. BMC Genomics 2010, 11:320
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PCR results. These indicated the precision and accuracy
of the miRNA microarray used in the present study.
Mir-210 promotes adipogenesis by repressing WNT 
signaling through targeting Tcf7l2
To validate the predicted targets and functions of these
identified miRNAs, a mimic of miR-210 was transfected
into 3T3-L1 cells for 24h before MDI induction, three
days later, 100% of cell differentiated into mature adipo-
cytes (Figure 4, B, C), while only less than 10% of the con-
trol cells differentiated (Figure 4, A, C). Meanwhile, qPCR
data (Additional file 2) showed the differentiated specific
factors such as Pparg and aP2 increased in transcription
level after transfection with the mimics of miR-210, while
both of the two factors decreased markedly after trans-
fection with the inhibitor of miR-210 (Figure 4, D, E). The
predicted target of miR-210, Tcf7l2 was repressed at the
transcriptional level in a dose-dependent manner (Figure
4, F), and the activity of luciferase reporter containing the
miR-210 binding site in the 3'UTR of Tcf7l2 mRNA (Fig-
ure 4, G) decreased for nearly 60% in HEK293FT cells
(Figure 4, H). In lithium-treated 3T3-L1 cells, β-catenin
protien was increased not only in the cytoplasm but also
in the nucleus after transfection with miR-210 (Figure 4,
I, J). These findings indicated that miR-210 promotes the
lipids formation by repressing WNT signaling through
targeting Tcf7l2.
Discussion
For years, the mechanism and development of lipid for-
mation have been actively investigated in the study of adi-
pogenesis and obesity [2,3,24]. Many studies about the
switch of adipogenesis, WNT signaling pathway, just
focused on protein-coding genes such as Wnt4, Wnt5 and
Wnt10b [8,24-26]. Recently, miRNAs have been found to
have wide-ranging regulatory functions in cell prolifera-
tion, differentiation and many other processes [27], but
only a few studies have focused on the interaction with
WNT signaling during adipogenesis. Strikingly, one
report showed that miRNAs have interaction with WNT
signaling during the adipogenesis and miR-8 family
members including miR-200a/b/c, miR-429 and miR-141
promoted adipogenesis [28]. Thus, miRNAs are believed
to elucidate the mechanism of adipogenesis by regulating
the Wnt/β-catenin signaling pathway [28]. In the current
study, WNT-suppressed cells (Model 1), i.e. pre-adipo-
cytes treated with a WNT-antagonist such as Insulin, dif-
ferentiated into mature adipocytes (Figure 1, B, C, G).
Figure 3 Validation of the microarray results by qRT-PCR. Preadip means pre-adipocytes, MDI means mature adipocytes, Li+Preadi means lithi-
um-treated pre-adipoctyes, Li+MDI means the lithium treated 3T3-L1 cells followed with MDI induction remaining un-differentiation cells. Y-axis in-
dicates the relative expression of the detected genes relative to the internal reference gene Gapdh; Fold amplifications are noted above.Qin et al. BMC Genomics 2010, 11:320
http://www.biomedcentral.com/1471-2164/11/320
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Meanwhile, the expression of adipocyte differentiation-
specific genes such as Pparg, Cebpa etc. increased signifi-
cantly (P < 0.01) after induction (Figure 2). These data
indicated that the WNT-suppressed cell model was suc-
cessfully established. In contrast, in the WNT-activated
cell model (Model 2), i.e. preadipocytes treated with the
WNT signaling activator lithium, adipogenesis was
blocked completely (Figure 1, E, F, G) and the expression
of adipogenesis-specific genes was totally suppressed (P <
0.01) (Figure 2), which suggests that the WNT-activated
cell model was successfully established and the following
experiments were reliable. Besides, combined investiga-
Figure 4 Mir-210 represses WNT signaling through targeting Tcf7l2 and promotes adipogenesis. (A) MDI induction for 3 days in 3T3-L1 cells; 
(B) Mir-210 mimics were transfected in 3T3-L1 cells and following 3 days' MDI induction; (C) Low amplification of 3T3-L1 cells with or without miR-210 
transfection following 3 days' MDI induction; (D) Relative expression of Pparg and (E) aP2 after transfection of miR-210 mimics and inhibitor; (F) Mir-
210 blocked the expression of Tcf7l2 at transcription level in dose-dependent manner in 3T3-L1 cells; (G) Mir-210 binding site in 3'UTR of Tcf7l2 (up) 
and the synthesized sequence of 3'UTR of Tcf7l2 with Xho1 and Not1 emzyme sites (down). (H) Mir-210 inhibits renilla luciferase reporter activity with 
3' UTR binding site derived from Tcf7l2 in HEK293FT cells; (I) Transfection of miR-210 increased the protein of β-catenin in cytoloplasm and (J) nucleus 
in 3T3-L1 cells.Qin et al. BMC Genomics 2010, 11:320
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tion of WNT signaling pathway and miRNAs could offer
a novel sight into the mechanism of adipogenesis.
According to the predicted potential function in adipo-
genesis by regulating WNT signaling, these miRNAs can
be divided into two sets; one that suppresses WNT sig-
naling and one that activates it. The former set should be
characterized by up-regulation in mature adipocytes and
down-regulation in both lithium-treated pre-adipocytes
and cells of the Li+MDI group. These miRNAs also target
the key factors in the WNT pathway, including members
of WNT family such as Wnt10b, Wnt1 and Axin2, and
molecules in the WNT pathway such as Lrp5/6, Tcf and
Dvl (Additional file 6). The aforementioned screened pat-
tern indicated that some miRNAs such as miR-103, miR-
210, miR-148a, miR-320 and miR-194 accorded with this
prediction. A previous report has shown that miR-103
was required for adipocyte differentiation, as confirmed
by northern blotting [17]. In the present study, miR-103,
which was markedly up-regulated in differentiating adi-
pocytes (P < 0.05), was predicted to target Wnt3a and
consequently to promote adipogenesis; Thus, our predic-
tion was consistent with the previous study. The second
set of miRNA (potentially activating Wnt/β-catenin sig-
naling) is characterized by down-regulation in mature
adipocytes and up-regulation in lithium-treated pre-adi-
pocytes and adipocytes in the Li+MDI group. Impor-
tantly, these miRNAs mostly target important
transcriptional factors or differentiation-specific marker
genes during adipogenesis, such as Pparg,  Cebpa  etc.
(Additional file 7). They included miR-301a, miR-130a/b,
miR-27a/b, miR-18a, miR-320 and miR-181a/b/c/d, and
were predicted to activate WNT signaling, resulting in
the suppression of adipogenesis. A previous study
showed that the miR-27 gene family was down-regulated
during adipocytes differentiation. Over-expression of
miR-27 specifically inhibited adipocytes formation and
blocked the expression of Pparg and Cebpa as well as fat
tissue in obese mice [29]. A similar result in the present
study validated this previous report. As shown in table 3,
miR-27b was up-regulated significantly by about 2.8-fold
(P < 0.01) in Li+MDI group cells, indicating that it was
less necessary for adipogenesis; Mir-27a/b was also pre-
dicted to target a master regulator in adipogenesis, i.e.
Pparg, indicating that they might be antagonistic to adi-
pogenesis, which was consistent with the previous report.
To sum up: using microarray data, we screened out two
sets of miRNAs that might play a role in suppressing or
activating WNT signaling during adipogenesis. This pre-
dicted pattern was shown in figure 5, which offers a
model for the study of adipogenesis related to miRNAs
and WNT signaling.
To date, only a small number of predicted targets have
been experimentally validated, so further investigation is
needed to clarify the function of these miRNAs [30-32].
Microarray data showed that miR-210 was up-regulated
in adipocytes, which suggested the potential role of miR-
210 in promoting lipogenesis. After transfection of miR-
210, the lipogenesis was dramatically promoted (Figure 4,
B, C), but when antagonizing miR-210, the differentiation
specific genes such as Pparg and ap2 were makedly sup-
pressed, which suggested the specific role of miR-210 in
promoting adipogenesis (Figure 4, D, E). Tcf7l2, a key
transcription factor in activation by WNT signaling [33],
is essential for the β-catenin/TCF complex downstream
of WNT signaling. As predicted, miR-210 targets Tcf7l2
with hybrid free energy -30.3 kcal/mol. After transfection
of miR-210, Tcf7l2 was markedly repressed at the tran-
scriptional level (Figure 4, F) and the activity of luciferase
reporter decreased markedly (Figure 4, H), which indi-
cated that miR-210 promoted the lipid formation and
Tcf7l2 should be targeted by miR-210. When WNT sig-
naling was activated by lithium, β-catenin protein
decreased dramatically. Interestingly, after transfection
with miR-210, the β-catenin protein increased not only in
the cytoplasm but also in the nucleus (Figure 4, I, J).
These lines of evidence suggested that miR-210 probably
Figure 5 The mode of miRNAs that regulate adipogenesis by 
modulating the canonical Wnt/β-catenin signaling pathway. (A) 
Predicted miRNAs targets in WNT signaling pathway such as Sfrp, Dkk, 
Frizzled, Gsk3, Apc and Dsh, resulting in the repression of adipogenesis; 
(B) Predicted miRNAs targets of WNT signaling pathway such as Wnt, 
Lrp, Axin and Tcf, resulting in activation of adipogenesis. This figure 
was modified from a previous report [39].Qin et al. BMC Genomics 2010, 11:320
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plays a role in promoting the adipogenesis and repressing
WNT signaling through targeting the transcription factor
Tcf7l2. These experiments not only validated our hypoth-
esis but also confirmed the accuracy and reliability of the
predicted target of these miRNAs.
Mir-143, which was reported to be required during adi-
pocyte differentiation [16], was not listed in our microar-
ray data. In the present study, microRNAs that changed
at least twofold and differed markedly (P < 0.05) between
the two cell models were identified as potentially interest-
ing. qRT-PCR showed that miR-143 expression in adipo-
cytes after seven days' differentiation was 1.41 fold higher
than in pre-adipocytes (data not shown). In a previous
study, northern blotting indicated that miR-143 changed
significantly on the 9th day after MDI induction, while
the sample in the current work was harvested on the 7th
day. As for the strict screening criterion, the expression of
miR-143 does not change dramatically before the 9th day
of differentiation and therefore was not shown in table
1[17].
The list of hybrids represents the free energies needed
for micrRNAs to bind their targets: the lower the value,
the more stable the binding, which offers an alternative
way of assessing the reliability of predictions. To evaluate
this screening criterion, we carried out experiments to
find a reliable hybrid score by transfection of miRNA in
vitro and conducting semi-quantitative PCR to detect the
target genes. The results showed a good correlation in the
miRNAs and predicted targets when the hybrid free
energy was less than -30 kcal/mol (data not shown). Con-
sistent with our observation, this criterion was validated
by other reports using a similar approach [17]. For exam-
ple, the hybrid free energy of miR-146a and its predicted
target wnt5a was -30.3 kcal/mol; our prediction was con-
firmed by previous study. Therefore, hybrid free energy is
recommended for consideration in the prediction of
miRNA targets; the prediction is more reliable when
hybrid score is less than -30 kcal/mol.
Conclusions
In summary, the current work used microarray experi-
ments to examine global miRNA expression in two 3T3-
L1 cell models, i.e. activation or suppression of WNT sig-
naling by MDI induction or lithium treatment. miRNA
target prediction and further functional characterization
of miR-210 will supplement the results of this study and
help to elucidate the specific roles in adipogenesis. The
findings demonstrated crosstalk between WNT signaling
and miRNAs, highlighting the role of miRNAs during
adipogenesis, i.e. repression and promotion of adipogen-
esis by regulating WNT signaling. The global changes in
miRNA expression discovered in the present study may
for the first time elucidate the preliminary mechanisms
underlying WNT signaling-mediated changes in lipid for-
mation during adipogenesis.
Methods
Cell culture and cell models construction
The 3T3-L1 (ATCC, CL-173TM) pre-adipocyte cell line
was maintained in Dulbecco's modified Eagle's medium
supplemented with 10% fetal bovine serum (Gibco, USA)
at 37°C in 5% CO2-air. To construct a cell model in which
WNT signaling was suppressed, 3T3-L1 cells were
allowed to reach confluence and then exposed to MDI
medium for three days; MDI contained 3-isobutyl-1-
methylxanthine (0.5 M), dexamethasone (1 μM) and
insulin (1.75 M). The cells were then cultured in high-glu-
cose DMEM, 10% FBS and insulin alone for the following
three days, and subsequently cultured with high-glucose
DMEM and 10% FBS, replaced at 2-day intervals before
the end of the checkpoint. To construct a cell model in
which WNT signaling was activated, LiCl was added to
the medium at a concentration of 25 mM. To determine
whether WNT signaling was activated, the cells were fur-
ther treated with MDI (Li+MDI treatment) to see
whether they differentiated into mature adipocytes.
RNA isolation and microarray experiment
Total RNA was extracted using a mirVana™ miRNA Isola-
tion kit (Ambion, Inc., Austin, TX) according to the man-
ufacturer's instructions. RNA quality was tested with
Agilent Bioanalyzer 2100 (Agilent Technologies, Santa
Clara, CA). Microarray hybridization was performed
using an Agilent's miRNA microarray system (V12.0),
covering 627 mouse miRNAs and 39 mouse viral miR-
NAs from miRBase database v 12 (Agilent Technologies,
Foster City, CA) [34]. Total RNA was directly labeled
using a Agilent's miRNA Complete Labeling and Hyb Kit
(p/n 5190-0456) with Cy3. Hybridization was carried out
at 65°C for 17 h and the arrays were then washed and
scanned on the Agilent Scan Control software, then ana-
lyzed with Feature Extraction Software 9.5.3 (Agilent)
using default parameters. Each sample was run in tripli-
cate and the data were normalized using standard proce-
dures [35].
Microarray data analysis
Differentially expressed miRNAs were identified using t-
tests with P-values < 0.05. The background-subtracted
data were then subjected to variance stabilization nor-
malization [36]. The data were further analyzed by clus-
tering, and expression profiles were visualized with
GeneSpring 10.0 (Agilent Technology).
Validation of differentially expressed miRNAs by qRT-PCR
To validate the accuracy of the microarray, a stem-loop
qRT-PCR assay based on SYBR Green I was performedQin et al. BMC Genomics 2010, 11:320
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on five miRNAs selected at random. The RT primers and
real-time PCR primers were designed as described [22].
Real-time PCR was performed using a Roche Light
Cycler 480 Real-Time PCR System. Briefly, 1 μg total
RNA was reverse-transcribed for 5 min at 72°C, 5 min on
ice, 60 min at 42°C, 5 min at 95°C. The 10 μl PCR reaction
system contained 100 ng cDNA and 0.2 μl universal
reverse and specific forward primers. The reaction proto-
col was 95°C for 5 min followed by 40 cycles at 95°C for
15 s, 60°C for 20 s and 72°C for 15 s. All reactions were
run in triplicate. The expression of each miRNA relative
to U6 RNA was determined by the 2-ΔCT method [37].
qPCR experiments were performed in triplicate and the
data are presented as mean ± SD.
Prediction and analysis of candidate miRNA targets
On line software packages were used to predict the genes
targeted by miRNAs. We mainly used TargetScan
[38]http://www.targetscan.org/mmu_50/ and hybrid
http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/sub-
mission.html.
Transfection with microRNA mimics and inhibitors
3T3-L1 cells were plated 1 day before transfection. The
duplex oligonucleotide (mimic) or single antisense of
miR-210 (inhibitor) (Ribobio, China) was transfected into
it using Lipofectamin 2000 (Invitrogen, USA) according
to the manufacturer's instructions. After 24 h transfec-
tion, the cells were harvested for further experiments.
Luciferase reporter assays
3'UTR segments containing the miR-210 binding site of
Tcf7l2 were synthesized and annealed into double strands
and inserted into the end of Renilla luciferase of the psi-
CHECK-2 vector (Promega, USA). HEK293FT cells were
transiently transfected for 24 h with the psiCHECK-
Tcf7l2, co-transfected with miR-210 mimics (10 ng) or a
scrambled miR-control (10 ng) and psiCHECK-Tcf7l2 (50
ng) or psiCHECK-Tcf7l2 mutant plasmid (50 ng, muta-
tion in the seed region in the 3'UTR of Tcf7l2), Data were
presented as normalized ratios of target (Renilla)
luciferase activity to control (Firefly) luciferase activity.
Each transfected well was assayed in triplicate.
Western blotting
Cytoplasmic and nuclear extracts were harvested with a
nuclear-protein kit (Biyotime, China), fractionated by
12% SDS polyacrylamide gel electrophoresis, electroblot-
ted on to a PVDF membrane using an iBlot™ Dry Blotting
System (Invitrogen, USA), and then blocked with TBST
containing 5% nonfat milk for 1 h at room temperature
and incubated overnight at 4°C in a solution containing
2.0 μg/mL mouse anti-mouse β-catenin (R&D, USA). The
membrane was then incubated at room temperature for 1
h in a solution containing a 1:2,000 dilution of HRP-con-
jugated sheep anti-mouse IgG, and the chemilumines-
cence was detected using ECL equipment (ImageQuant
RT ECL, GE, USA).
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